首页> 外文OA文献 >Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

【2h】

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

机译：肿瘤突变负担和PTEN改变作为对PD-1 / L1阻断在转移性三重阴性乳腺癌中的反应的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Romualdo Barroso-Sousa; Tanya E. Keenan; Sonia Pernas; Pedro Exman; Esha Jain; Ana C. Garrido-Castro; Melissa Hughes; Brittany Bychkovsky; Renato Umeton; Janet L. Files; Neal I. Lindeman; Laura E. MacConaill; F. Stephen Hodi; Ian E. Krop; Deborah Dillon; Eric P. Winer; Nikhil Wagle; Nancy U. Lin; Elizabeth A. Mittendorf; Eliezer M. Van Allen; Sara M. Tolaney;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer [J] . Barroso-Sousa Romualdo, Keenan Tanya E., Pernas Sonia, Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第11期

机译：肿瘤突变负担和PTEN改变作为对PD-1 / L1阻断在转移性三重阴性乳腺癌中的反应的相关性
2. Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden [J] . Ankur R Parikh, Siraj M Ali, Alexa B Schrock, Lung Cancer: Targets and Therapy . 2018,第3期

机译：对具有高肿瘤突变负担的PTEN突变的转移性非小细胞肺癌对雷帕霉素类似物而非PD-1抑制剂的反应
3. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial [J] . Voorwerk Leonie, Slagter Maarten, Horlings Hugo M., Nature medicine . 2019,第6期

机译：免疫诱导策略转移性三重阴性乳腺癌，增强PD-1封锁的敏感性：滋补试验
4. Recognition of Non-synonymous Somatic Mutations by Tumor Infiltrating Lymphocytes (TIL) in Metastatic Breast Cancer [C] . Nikos Zacharakis International Symposium on Mathematical and Computational Oncology . 2019

机译：转移性乳腺癌中肿瘤浸润淋巴细胞（TIL）的非同义体细胞突变的识别。
5. Regulation and action of SKP2 and RhoA in cell and tumor models: Investigation into the molecular mechanisms responsible for the aggressive phenotype of triple-negative breast cancer. [D] . Fagan-Solis, Katerina D. 2013

机译：在细胞和肿瘤模型中SKP2和RhoA的调控和作用：调查导致三阴性乳腺癌的侵袭性表型的分子机制。
6. Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden [O] . Ankur R Parikh, Siraj M Ali, Alexa B Schrock, 2018

机译：对具有高肿瘤突变负担的PTEN突变的转移性非小细胞肺癌对雷帕霉素类似物而非PD-1抑制剂的反应
7. Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden [O] . Ankur R Parikh, Siraj M Ali, Alexa B Schrock, 2018

机译：对雷帕霉素类似物的反应，但在PTEN突变的转移性非小细胞肺癌中没有PD-1抑制剂，具有高肿瘤突变负担

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅